Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

There has been a worldwide increase in infections caused by drug-resistant Gram-negative pathogens, including carbapenem-resistant Enterobacteriaceae (CRE). Meropenem-vaborbactam, a carbapenem antibiotic and novel boronic acid-based beta-lactamase inhibitor, is a fixed-dose combination product with...

Descripción completa

Detalles Bibliográficos
Autores principales: Petty, Lindsay A, Henig, Oryan, Patel, Twisha S, Pogue, Jason M, Kaye, Keith S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140735/
https://www.ncbi.nlm.nih.gov/pubmed/30254477
http://dx.doi.org/10.2147/IDR.S150447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140735/
https://www.ncbi.nlm.nih.gov/pubmed/30254477
http://dx.doi.org/10.2147/IDR.S150447

Ejemplares similares